Keep abreast of the latest in stem cell and regenerative health developments with your go-to resource for understanding the evolving global landscape of regulations in regenerative medicine. As this innovative field continues to advance, countries worldwide are adopting diverse frameworks to ensure the safety, efficacy, and accessibility of regenerative therapies, including stem cell treatments, gene therapies, and tissue-engineered products. From the FDA’s expedited pathways in the U.S. to Japan’s fast-track approval systems and the European Union’s centralized processes for advanced therapies, this section explores how regulatory bodies are adapting to meet the challenges of this rapidly growing sector.